| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amrubicin as second- or third-line treatment for women with metastatic HER2-negative breast cancer: a Sarah Cannon Research Institute phase 1/2 trial
|
Yardley, Denise A.
|
|
2014
|
148 |
3 |
p. 535-540
|
artikel
|
| 2 |
A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer
|
Gholami, Sepideh
|
|
2014
|
148 |
3 |
p. 489-499
|
artikel
|
| 3 |
A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer
|
Gholami, Sepideh
|
|
|
148 |
3 |
p. 489-499
|
artikel
|
| 4 |
Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer
|
Vyas, Ami
|
|
2014
|
148 |
3 |
p. 645-654
|
artikel
|
| 5 |
Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype
|
Schmitz, Alexander M. Th.
|
|
2014
|
148 |
3 |
p. 541-551
|
artikel
|
| 6 |
Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: results from a multicenter study in Italy
|
Ottini, L.
|
|
2014
|
148 |
3 |
p. 623-628
|
artikel
|
| 7 |
BCRT response to Moller
|
Evans, D. Gareth
|
|
2014
|
148 |
3 |
p. 693
|
artikel
|
| 8 |
Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers
|
Pfeifer, Werner
|
|
2014
|
148 |
3 |
p. 675-683
|
artikel
|
| 9 |
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers
|
Loud, Jennifer T.
|
|
2014
|
148 |
3 |
p. 691-692
|
artikel
|
| 10 |
Concerns about methods for determination of estrogens in body fluids
|
Chatterton, Robert T.
|
|
2014
|
148 |
3 |
p. 685
|
artikel
|
| 11 |
Degree of urbanization and mammographic density in Dutch breast cancer screening participants: results from the EPIC-NL cohort
|
Emaus, Marleen J.
|
|
2014
|
148 |
3 |
p. 655-663
|
artikel
|
| 12 |
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)
|
Saloustros, Emmanouil
|
|
2014
|
148 |
3 |
p. 591-597
|
artikel
|
| 13 |
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies
|
Twelves, Chris
|
|
2014
|
148 |
3 |
p. 553-561
|
artikel
|
| 14 |
Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer
|
Severi, Gianluca
|
|
2014
|
148 |
3 |
p. 665-673
|
artikel
|
| 15 |
Erratum to: Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours
|
Browne, Brigid C.
|
|
2014
|
148 |
3 |
p. 697
|
artikel
|
| 16 |
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis
|
Drukker, C. A.
|
|
2014
|
148 |
3 |
p. 599-613
|
artikel
|
| 17 |
Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast
|
Cloyd, Jordan M.
|
|
2014
|
148 |
3 |
p. 637-644
|
artikel
|
| 18 |
Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets
|
Ononye, S. N.
|
|
2014
|
148 |
3 |
p. 477-488
|
artikel
|
| 19 |
Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer
|
Gupta, Satish
|
|
2014
|
148 |
3 |
p. 615-622
|
artikel
|
| 20 |
MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
|
Tharmaratnam, Kukatharmini
|
|
2014
|
148 |
3 |
p. 687-688
|
artikel
|
| 21 |
Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models
|
Gad, Ekram
|
|
2014
|
148 |
3 |
p. 501-510
|
artikel
|
| 22 |
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer
|
Palmieri, C.
|
|
2014
|
148 |
3 |
p. 581-590
|
artikel
|
| 23 |
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14
|
Coppa, Anna
|
|
2014
|
148 |
3 |
p. 629-635
|
artikel
|
| 24 |
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
|
Balmativola, D.
|
|
2014
|
148 |
3 |
p. 511-523
|
artikel
|
| 25 |
Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer
|
Rangel, Leticia B. A.
|
|
2014
|
148 |
3 |
p. 571-580
|
artikel
|
| 26 |
Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy
|
Mortimer, Joanne
|
|
2014
|
148 |
3 |
p. 563-570
|
artikel
|
| 27 |
The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia
|
Imyanitov, Evgeny
|
|
2014
|
148 |
3 |
p. 695-696
|
artikel
|
| 28 |
The frequency of the BLM p.Q548X (c.1642C>T) mutation in breast cancer patients from Russia is no higher than in the general population
|
Anisimenko, Maksim S.
|
|
2014
|
148 |
3 |
p. 689-690
|
artikel
|
| 29 |
The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
|
Ibrahim, Ezzeldin M.
|
|
2014
|
148 |
3 |
p. 467-476
|
artikel
|
| 30 |
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
|
Miyashita, Minoru
|
|
2014
|
148 |
3 |
p. 525-534
|
artikel
|
Tijdschrift beschrijving